The purpose of this study is to investigate and document real life safety and satisfaction of re-use of urethral catheters for intermittent self catheterization. The study will collect re-used catheters from included patients and compare those to a control group with regard to bacterial contamination and mechanical properties. A four week prospective evaluation will follow where the patients will be given catheters intended for single-use.

Inclusion Criteria:

• Provision of informed consent

• Female and/or male aged 18 years and over

• Intermittent self-catheterization as primary bladder management method, defined as a normal catheterization frequency of at least 4 times daily

• Reuse of the same silicon, rubber (latex) or plastic (e.g. vinyl, PVC) catheter

• Accustomed intermittent catheterization user, defined as intermittent catheterization use for at least 3 months

• Able to use catheters of size:

  40 cm, CH12 or CH14; 16'', FR12 or FR14; 15 cm, CH10 or CH12; 6'', FR10 or FR12;

Exclusion Criteria:

• Antibiotic treatment within 4 weeks prior study inclusion
• Drug or alcohol abuse or other disease of addiction
• Immunocompromising diseases or medications
• Known urological/renal anatomical abnormalities with potential impact on subject´s compliance as judged by the investigator
• Diagnosis of severe fecal incontinence that may compromise study participation as judged by the investigator
• Involvement in the planning and conduct of the study (applies to both Wellspect HealthCare staff and staff at the study site)
• Previous enrollment in the present study
• Simultaneous participation in another clinical study that may interfere with the present study, as judged by the investigator
• Severe non-compliance to protocol as judged by the investigator and/or Wellspect HealthCare